Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin for Acute Large Vessel Occlusive Stroke (ARISE)
NCT06538844Phase 2Completed
- Sponsor
- Capital Medical University
- Start
- Aug 2024
- Primary completion
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of albumin (human) in ischemic stroke, sponsored by Capital Medical University. Started Aug 2024; status: completed.
02
Drugs
albumin (human)
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06538844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06538844.